Evidence that stimulatory dopamine receptors may be involved in the regulation of prolactin secretion. 1994

T E Porter, and D Grandy, and J Bunzow, and C D Wiles, and O Civelli, and L S Frawley
Department of Cell Biology and Anatomy, Medical University of South Carolina, Charleston 29425.

It is well established that dopamine (DA) effectively inhibits PRL secretion from anterior pituitary mammotropes via D2-DA receptors. Paradoxically, it is reported that the monoamine can actually increase PRL release under appropriate experimental conditions. Although the mechanism underlying this stimulatory effect remains undefined, the ability of D1- and D5-DA receptors to activate adenylyl cyclase raises the possibility that a similar receptor subtype is present in the anterior pituitary and mediates the stimulatory effects of DA on PRL release. The purpose of the present study was to explore this possibility. First, we tested whether D1 and D5 receptors could couple to and stimulate PRL secretion. Subclones of GH4C1 cells (which secrete PRL, but do not express DA receptors) stably expressing human D1 or D5 receptors were treated with DA (10(-16)-10(-6) M), and the medium PRL content was measured by RIA. Subclones transfected with short or long forms of the human D2 receptor were also tested. As expected, DA (10(-6) M) inhibited PRL release from cells expressing either short or long D2 receptors by 41% and 39%, respectively (P < 0.01; n = 4 separate experiments). In contrast, comparable concentrations of DA (10(-(8) and 10(-6) M) increased PRL release from cells expressing D1 or D5 receptors by 76% and 122%, respectively (P < 0.01; n = 4). Thus, both D1 and D5 receptors were fully capable of stimulating PRL release from transfected GH4C1 cells. We next sought to determine whether the gene for at least one of these structurally similar receptors was expressed in rat anterior pituitary tissue. First strand cDNA was synthesized, using a rat D5-specific oligonucleotide primer and reverse transcriptase, from total RNA extracted from the anterior pituitary glands of five lactating female rats. The specifically primed cDNA then served as a template for 35 cycles of polymerase chain reaction amplification in which nested primers specific for the rat D5 receptor were used. Electrophoresis of the DNA resolved a 696-basepair band corresponding to a fragment of the D5 receptor in each of five anterior pituitary samples (verified by digestion with three different restriction endonucleases). Taken together, these results demonstrate that both D1 and D5 receptors are capable of mediating the stimulatory effects of DA on PRL release and that the mRNA for DA D5 receptors is present in rat anterior pituitary glands. Our findings support the view that PRL release in vivo may be modulated via one or more stimulatory DA receptors.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D017447 Receptors, Dopamine D1 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLYL CYCLASES. Dopamine D1 Receptors,Dopamine-D1 Receptor,D1 Receptors, Dopamine,Dopamine D1 Receptor,Receptor, Dopamine-D1
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2

Related Publications

T E Porter, and D Grandy, and J Bunzow, and C D Wiles, and O Civelli, and L S Frawley
January 1980, Advances in biochemical psychopharmacology,
T E Porter, and D Grandy, and J Bunzow, and C D Wiles, and O Civelli, and L S Frawley
February 1982, Gastroenterologie clinique et biologique,
T E Porter, and D Grandy, and J Bunzow, and C D Wiles, and O Civelli, and L S Frawley
February 1989, Endocrinology,
T E Porter, and D Grandy, and J Bunzow, and C D Wiles, and O Civelli, and L S Frawley
March 1992, Neuroendocrinology,
T E Porter, and D Grandy, and J Bunzow, and C D Wiles, and O Civelli, and L S Frawley
December 1983, European journal of pharmacology,
T E Porter, and D Grandy, and J Bunzow, and C D Wiles, and O Civelli, and L S Frawley
April 1995, General and comparative endocrinology,
T E Porter, and D Grandy, and J Bunzow, and C D Wiles, and O Civelli, and L S Frawley
December 1988, Acta endocrinologica,
T E Porter, and D Grandy, and J Bunzow, and C D Wiles, and O Civelli, and L S Frawley
March 1977, Endocrinology,
T E Porter, and D Grandy, and J Bunzow, and C D Wiles, and O Civelli, and L S Frawley
November 1981, European journal of pharmacology,
Copied contents to your clipboard!